Lipella Pharmaceuticals Inc. announced that its abstract on LP-10, a liposomal tacrolimus oral rinse for treating Oral Lichen Planus (OLP), will be presented by Dr. Alessandro Villa at the 2025 joint ...
All 27 patients completed treatment with no serious adverse events, underscoring a favorable safety profile Statistically significant improvements achieved across all efficacy endpoints at the 4-week ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback